|
Press Release
Skila Launches iKOL Premium - Oncology Focus
Morris Plains, NJ , November 5, 2010 – Skila, the life science industry’s leading provider of knowledge agility and stakeholder collaboration management solutions announces the launch of iKOL Premium – Oncology Focus. Last year, Skila introduced iKOL, a tool to identify, verify, develop and understand key opinion leaders, scientific experts, product advocates, clinical investigators and key institutions. Now Skila is offering even more in-depth web-based knowledge Intelligrated™ from more than 50 sources, covering more than a decade of information that includes experts in positions of significance at associations, journals, guideline committees and conferences related to oncology.
Most thought leaders consist of physicians and other stakeholders who have earned credibility with their medical colleagues based on expertise and scientific stature. The life sciences industry depends on these thought leaders to diffuse scientific information regarding innovative treatments and new products making them a critical component of the industry’s marketing, sales and medical strategies. With the introduction of the iKOL Premium – Oncology Focus, Skila offers clients the most robust tool for identifying and validating thought leaders on the market.
iKOL Premium provides on-demand access to more than 3.8 million professionals in more than 120 areas of expertise in 100+ countries. The 360º live dynamic profiles allow users to make better decisions with real-time knowledge of expert’s cited work and research activity. The collaboration network tool displays the strength and length of relationships among collaborators and affiliations. Advanced search criteria and capabilities help to uncover rising stars and emerging experts. With the oncology focused solution, users can use key information, such as committee members, faculty members, journal editorial staff, guideline authors and more to weight relevant experts and compare results among peers.
|
About Skila
Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.
BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.
To receive more information:

Do You Skila?
|